Richard P. Blumberg - 10 Apr 2025 Form 4 Insider Report for GUIDED THERAPEUTICS INC (GTHP)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
05 Sep 2025, 16:03:35 UTC
Prior SEC filing
24 Oct 2024
Next SEC filing
05 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Richard P. Blumberg

Key filing fact

Richard P. Blumberg filed Form 4 for GUIDED THERAPEUTICS INC (GTHP) on 05 Sep 2025.

Key facts

  • This page summarizes Richard P. Blumberg's Form 4 filing for GUIDED THERAPEUTICS INC (GTHP).
  • 6 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 05 Sep 2025, 16:03.

Change

  • Previous filing in this sequence was filed on 24 Oct 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001486345 Primary reporting owner

Blumberg Richard P.

Relationship
Director, 10%+ Owner
Address
5835 PEACHTREE CORNERS EAST, STE. B, PEACHTREE CORNERS
Signature
/s/ Richard P. Blumberg
Signature date
04 Sep 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GTHP transaction

Common Stock

Other

Transaction value
Shares
+165,481
Change %
+2.5%
Price
Shares after
6,855,206
Date
10 Apr 2025
Ownership
Direct
Footnotes
F1
GTHP transaction

Common Stock

Other

Transaction value
Shares
+55,853
Change %
+0.81%
Price
Shares after
6,911,059
Date
10 Apr 2025
Ownership
Direct
Footnotes
F2
GTHP transaction

Common Stock

Other

Transaction value
Shares
+81,121
Change %
+1.2%
Price
Shares after
6,992,180
Date
21 Aug 2025
Ownership
Direct
Footnotes
F4
GTHP transaction

Preferred Series E Stock

Other

Transaction value
Shares
-233
Change %
-100%
Price
Shares after
0
Date
21 Aug 2025
Ownership
Direct
Footnotes
F5
GTHP transaction

Common Stock

Other

Transaction value
Shares
+932,000
Change %
+13%
Price
Shares after
7,924,180
Date
21 Aug 2025
Ownership
Direct
Footnotes
F5

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GTHP transaction Derivative

Stock Options

Award

Transaction value
$0
Shares
+110,000
Change %
Price
$0.000000
Shares after
110,000
Date
03 Jun 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
110,000
Exercise price
$0.1400
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

These shares were issued for payment of accrued dividends on the reporting individual's Series F preferred stock, at a conversion price of $0.0943.

Footnote F2

These shares were issued for payment of accrued dividends on the reporting individual's Series F-2 preferred stock, at a conversion price of $0.0943.

Footnote F3

One-fourth of the shares are subject to the award vested on June 3, 2025; the remaining shares will vest monthly, starting on September 3, 2025, subject to the reporting person's continued service on each such date, until the award is fully vested on June 2, 2028.

Footnote F4

These shares were issued for payment of accrued dividends on the reporting individual's Series E preferred stock, at a conversion price of $0.2298.

Footnote F5

On August 21, 2025, Mr. Blumberg (WMB Pension Plan fbo Richard Blumberg) converted 233 shares of Series E preferred stock into 932,000 shares of common stock. The Series E preferred stock had a stated value of $1,000 and $0.25 exercise price.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .